Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-11
1998-08-04
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424450, 530326, A61K 3816
Patent
active
057893810
ABSTRACT:
The present invention discloses useful peptides and synthetic pulmonary surfactants, as well as methods of making and using same. In one preferred embodiment, a synthetic pulmonary surfactant comprises one or more pharmaceutically acceptable phospholipids admixed with a polypeptide comprising at least 10 amino acid residues and no more than about 60 amino acid residues, said polypeptide including a sequence having alternating hydrophobic and hydrophilic amino acid residue regions. In other embodiments, a surfactant peptide has an amino acid residue sequence selected from the group consisting of KLLLLKLLLLKLLLLKLLLLK, KLLLLLLLLKLLLLLLLLKLL, and KKLLLLLLLKKLLLLLLLKKL.
REFERENCES:
patent: 4562003 (1985-12-01), Lewicki
patent: 4643988 (1987-02-01), Segrest et al.
patent: 4656253 (1987-04-01), Lewicki
patent: 4861756 (1989-08-01), Jackson
patent: 5164369 (1992-11-01), Cochrane et al.
patent: 5260273 (1993-11-01), Cochrane et al.
patent: 5407914 (1995-04-01), Cochrane et al.
Cochrane Charles G.
Revak Susan D.
Delaney Patrick R.
The Scripps Research Institute
Tsang Cecilia J.
LandOfFree
Pulmonary surfactant proteins and related polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pulmonary surfactant proteins and related polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulmonary surfactant proteins and related polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177218